These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
415 related articles for article (PubMed ID: 35941638)
1. Screening and identification of immune-related genes for immunotherapy and prognostic assessment in colorectal cancer patients. Wang S; Cheng L; Jing F; Li G BMC Med Genomics; 2022 Aug; 15(1):177. PubMed ID: 35941638 [TBL] [Abstract][Full Text] [Related]
2. Identification of prognostic immune-related gene signature associated with tumor microenvironment of colorectal cancer. Wang Y; Li W; Jin X; Jiang X; Guo S; Xu F; Su X; Wang G; Zhao Z; Gu X BMC Cancer; 2021 Aug; 21(1):905. PubMed ID: 34364366 [TBL] [Abstract][Full Text] [Related]
3. Identification and validation of an immune prognostic signature in colorectal cancer. Li M; Wang H; Li W; Peng Y; Xu F; Shang J; Dong S; Bu L; Wang H; Wei W; Hu Q; Liu L; Zhao Q Int Immunopharmacol; 2020 Nov; 88():106868. PubMed ID: 32771948 [TBL] [Abstract][Full Text] [Related]
4. A novel risk score based on immune-related genes for hepatocellular carcinoma as a reliable prognostic biomarker and correlated with immune infiltration. Long M; Zhou Z; Wei X; Lin Q; Qiu M; Zhou Y; Chen P; Jiang Y; Wen Q; Liu Y; Li R; Zhou X; Yu H Front Immunol; 2022; 13():1023349. PubMed ID: 36353638 [TBL] [Abstract][Full Text] [Related]
5. Identification of a prognostic gene signature based on an immunogenomic landscape analysis of bladder cancer. Luo Y; Chen L; Zhou Q; Xiong Y; Wang G; Liu X; Xiao Y; Ju L; Wang X J Cell Mol Med; 2020 Nov; 24(22):13370-13382. PubMed ID: 33048468 [TBL] [Abstract][Full Text] [Related]
6. A Prognostic Model Based on the Immune-related Genes in Colon Adenocarcinoma. Sun YL; Zhang Y; Guo YC; Yang ZH; Xu YC Int J Med Sci; 2020; 17(13):1879-1896. PubMed ID: 32788867 [No Abstract] [Full Text] [Related]
7. Up-regulation of S100P predicts the poor long-term survival and construction of prognostic signature for survival and immunotherapy in patients with pancreatic cancer. Zou W; Li L; Wang Z; Jiang N; Wang F; Hu M; Liu R Bioengineered; 2021 Dec; 12(1):9006-9020. PubMed ID: 34654352 [TBL] [Abstract][Full Text] [Related]
8. A novel prognostic signature of immune-related genes for patients with colorectal cancer. Wang J; Yu S; Chen G; Kang M; Jin X; Huang Y; Lin L; Wu D; Wang L; Chen J J Cell Mol Med; 2020 Aug; 24(15):8491-8504. PubMed ID: 32564470 [TBL] [Abstract][Full Text] [Related]
9. Development of a prognostic index and screening of potential biomarkers based on immunogenomic landscape analysis of colorectal cancer. Lin K; Huang J; Luo H; Luo C; Zhu X; Bu F; Xiao H; Xiao L; Zhu Z Aging (Albany NY); 2020 Mar; 12(7):5832-5857. PubMed ID: 32235004 [TBL] [Abstract][Full Text] [Related]
10. A five-immune-related genes-based prognostic signature for colorectal cancer. Zhu L; Wang H; Wang Z Int Immunopharmacol; 2020 Nov; 88():106866. PubMed ID: 32781411 [TBL] [Abstract][Full Text] [Related]
11. A novel prognostic index of hepatocellular carcinoma based on immunogenomic landscape analysis. Xiao H; Wang B; Xiong HX; Guan JF; Wang J; Tan T; Lin K; Zou SB; Hu ZG; Wang K J Cell Physiol; 2021 Apr; 236(4):2572-2591. PubMed ID: 32853412 [TBL] [Abstract][Full Text] [Related]
12. A novel prognostic risk score model based on immune-related genes in patients with stage IV colorectal cancer. Xu K; He J; Zhang J; Liu T; Yang F; Ren T Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33034614 [TBL] [Abstract][Full Text] [Related]
13. Development and validation of an immune-related gene prognostic model for stomach adenocarcinoma. Wu M; Xia Y; Wang Y; Fan F; Li X; Song J; Ding J Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33112406 [TBL] [Abstract][Full Text] [Related]
14. Construction of an immune gene expression meta signature to assess the prognostic risk of colorectal cancer patients. Orozco-Castaño C; Mejia-Garcia A; Zambrano Y; Combita AL; Parra-Medina R; Bonilla DA; González A; Odriozola A Adv Genet; 2024; 112():207-254. PubMed ID: 39396837 [TBL] [Abstract][Full Text] [Related]
15. Prognostic Risk Model of Immune-Related Genes in Colorectal Cancer. Qian Y; Wei J; Lu W; Sun F; Hwang M; Jiang K; Fu D; Zhou X; Kong X; Zhu Y; Xiao Q; Hu Y; Ding K Front Genet; 2021; 12():619611. PubMed ID: 33747044 [TBL] [Abstract][Full Text] [Related]
16. Identification of immune-related genes as prognostic factors in bladder cancer. Zhu J; Wang H; Ma T; He Y; Shen M; Song W; Wang JJ; Shi JP; Wu MY; Liu C; Wang WJ; Huang YQ Sci Rep; 2020 Nov; 10(1):19695. PubMed ID: 33184436 [TBL] [Abstract][Full Text] [Related]
17. Construction of a Novel Immune-Related mRNA Signature to Predict the Prognosis and Immune Characteristics of Human Colorectal Cancer. Li J; Han T; Wang X; Wang Y; Chen X; Chen W; Yang Q Front Genet; 2022; 13():851373. PubMed ID: 35401707 [No Abstract] [Full Text] [Related]
18. Development of a prognostic index and screening of prognosis related genes based on an immunogenomic landscape analysis of bladder cancer. Qu G; Liu Z; Yang G; Xu Y; Xiang M; Tang C Aging (Albany NY); 2021 Apr; 13(8):12099-12112. PubMed ID: 33888644 [TBL] [Abstract][Full Text] [Related]
19. A robust signature associated with patient prognosis and tumor immune microenvironment based on immune-related genes in lung squamous cell carcinoma. Zhou H; Zhang H; Shi M; Wang J; Huang Z; Shi J Int Immunopharmacol; 2020 Nov; 88():106856. PubMed ID: 32777677 [TBL] [Abstract][Full Text] [Related]
20. Establishment of an immune-related gene prognostic model for head and neck tumors. Zhou F; Chen AX; Lv HY; Liang DH; Yu HS J Biol Regul Homeost Agents; 2021; 35(3):975-986. PubMed ID: 34159769 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]